LOXL2 and Interstitial cardiac fibrosis: However, Loxl2 knockout prevented TAC-induced cardiac interstitial fibrosis and dysfunction (Fig. 5b–e), but no effects on myocyte hypertrophy (Supplementary Fig. 4a).